financetom
Business
financetom
/
Business
/
BHP and Lundin Mining boost copper access, to buy Filo for $3.25 bln
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BHP and Lundin Mining boost copper access, to buy Filo for $3.25 bln
Jul 29, 2024 6:05 PM

MELBOURNE, July 29 (Reuters) - Global miner BHP Group ( BHP )

and Canada-listed Lundin Mining ( LUNMF ) will jointly

take over developer Filo Corp ( FLMMF ) for C$4.5 billion ($3.25

billion), the companies said on Monday, as they move to progress

the South American projects.

BHP and Lundin will form a 50/50 joint venture to hold both

the Filo ( FLMMF ) del Sol and Josemaria projects around the

Argentine-Chile border.

BHP and Lundin have offered C$33 per Filo ( FLMMF ) share, reflecting

a 12.2% premium to the Canadian copper miner's last close on

Monday. Under the deal, BHP is expected to pay a total of $2.1

billion in cash.

Reuters reported on July 12 that Lundin and BHP were

weighing a joint bid.

The deal comes as miners race to build out their pipelines

of copper, a metal whose use is expected to underpin the energy

transition.

The world's biggest miners are increasingly preferring to

buy instead of building assets to grow, given rising costs for

developing new mines and a blow-out in time lines for regulatory

approvals.

BHP in May walked away from a blockbuster $49 billion bid to

take over Anglo American which rejected three proposed

offers from its bigger rival over the course of six weeks.

($1 = 1.3854 Canadian dollars)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US auto sales set to rise in August on Labor Day weekend surge, report shows
US auto sales set to rise in August on Labor Day weekend surge, report shows
Aug 29, 2024
Aug 29 (Reuters) - New vehicle sales in the United States are projected to rise over 4% in August from a year ago, partly boosted by the Labor Day weekend falling within the reporting period, according to a joint report by industry consultants J.D. Power and GlobalData ( GLDAF ) on Thursday. On a seasonally adjusted annualized rate (SAAR) basis,...
OpenAI, Anthropic sign deals with US govt for AI research and testing
OpenAI, Anthropic sign deals with US govt for AI research and testing
Aug 29, 2024
Aug 29 (Reuters) - AI startups OpenAI and Anthropic have signed deals with the United States government for research, testing and evaluation of their artificial intelligence models, the U.S. Artificial Intelligence Safety Institute said on Thursday. The first-of-their-kind agreements come at a time when the companies are facing regulatory scrutiny over safe and ethical use of AI technologies. California legislators...
Brown-Forman Fiscal Q1 Earnings, Net Sales Fall
Brown-Forman Fiscal Q1 Earnings, Net Sales Fall
Aug 29, 2024
08:33 AM EDT, 08/29/2024 (MT Newswires) -- Brown-Forman (BF.A, BF.B) reported fiscal Q1 earnings Thursday of $0.41 per diluted share, down from $0.48 a year earlier. Analysts polled by Capital IQ expected $0.46. Net sales for the fiscal quarter ended July 31 was $951 million, down from $1.04 billion a year earlier. Analysts surveyed by Capital IQ expected $990.8 million....
Johnson & Johnson Submits BLA to FDA for Nipocalimab Approval As Treatment of Chronic Neuromuscular Disease
Johnson & Johnson Submits BLA to FDA for Nipocalimab Approval As Treatment of Chronic Neuromuscular Disease
Aug 29, 2024
08:47 AM EDT, 08/29/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Thursday it has submitted a Biologics License Application to the US Food and Drug Administration for the approval of nipocalimab to treat generalized myasthenia gravis, a chronic neuromuscular disease that causes weakness in the voluntary muscles. The application was based on the company's phase 3 Vivacity-MG3...
Copyright 2023-2026 - www.financetom.com All Rights Reserved